Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Senti Biosciences (SNTI) Accumulated Depreciation & Amortization (2021 - 2025)

Senti Biosciences (SNTI) has 4 years of Accumulated Depreciation & Amortization data on record, last reported at $11.3 million in Q2 2025.

  • For Q2 2025, Accumulated Depreciation & Amortization changed N/A year-over-year to $11.3 million; the TTM value through Jun 2025 reached $11.3 million, changed N/A, while the annual FY2024 figure was $9.6 million, 54.5% up from the prior year.
  • Accumulated Depreciation & Amortization reached $11.3 million in Q2 2025 per SNTI's latest filing, up from $10.5 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $11.3 million in Q2 2025 and bottomed at $3.0 million in Q4 2022.
  • Average Accumulated Depreciation & Amortization over 4 years is $7.4 million, with a median of $7.9 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: surged 109.2% in 2023, then surged 54.5% in 2024.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $3.0 million in 2022, then soared by 109.2% to $6.2 million in 2023, then soared by 54.5% to $9.6 million in 2024, then grew by 17.91% to $11.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $11.3 million in Q2 2025, $10.5 million in Q1 2025, and $9.6 million in Q4 2024.